Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clayton

Showing results (531-540 of 569) with videos related to

Pageof 57
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 1, 2009
Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory painAdrian Hall, Andy Billinton, Susan H Brown, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 30, 2019
Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patientsM E S Smith-Uffen, S B Johnson, A J Martin, et al.
Contemporary Clinical Trials|January 1, 2025
Enhanced Advance care planning and life Review Longitudinal Intervention (EARLI): Protocol for a cluster randomized controlled cross-over trial of life story work and facilitated advance care planning among older Australian adults in community settingsAva Karusoo-Musumeci, Ling Yeoh, Rebecca Walton, et al.
Circulation|June 29, 1999
Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertensionD Langleben, R J Barst, D Badesch, et al.
Journal of Medicinal Chemistry|September 12, 2009
Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic painGerard M P Giblin, Andrew Billinton, Michael Briggs, et al.
The Journal of Clinical Endocrinology and Metabolism|December 22, 1999
Mendelian diseases among Roman Jews: implications for the origins of disease allelesC Oddoux, E Guillen-Navarro, C Ditivoli, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.
The American Journal of Cardiology|September 1, 1999
Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertensionA L Hinderliter, P W Willis, W Long, et al.
The Review of Scientific Instruments|May 2, 2016
An apparatus for studying electrical breakdown in liquid helium at 0.4 K and testing electrode materials for the neutron electric dipole moment experiment at the Spallation Neutron SourceT M Ito, J C Ramsey, W Yao, et al.
Pageof 57

Showing results (531-540 of 569) with videos related to

Sort By:
Pageof 57
Bioorganic & Medicinal Chemistry Letters|April 1, 2009
Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory painAdrian Hall, Andy Billinton, Susan H Brown, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 30, 2019
Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patientsM E S Smith-Uffen, S B Johnson, A J Martin, et al.
Contemporary Clinical Trials|January 1, 2025
Enhanced Advance care planning and life Review Longitudinal Intervention (EARLI): Protocol for a cluster randomized controlled cross-over trial of life story work and facilitated advance care planning among older Australian adults in community settingsAva Karusoo-Musumeci, Ling Yeoh, Rebecca Walton, et al.
Circulation|June 29, 1999
Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertensionD Langleben, R J Barst, D Badesch, et al.
Journal of Medicinal Chemistry|September 12, 2009
Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic painGerard M P Giblin, Andrew Billinton, Michael Briggs, et al.
The Journal of Clinical Endocrinology and Metabolism|December 22, 1999
Mendelian diseases among Roman Jews: implications for the origins of disease allelesC Oddoux, E Guillen-Navarro, C Ditivoli, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.
The American Journal of Cardiology|September 1, 1999
Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertensionA L Hinderliter, P W Willis, W Long, et al.
The Review of Scientific Instruments|May 2, 2016
An apparatus for studying electrical breakdown in liquid helium at 0.4 K and testing electrode materials for the neutron electric dipole moment experiment at the Spallation Neutron SourceT M Ito, J C Ramsey, W Yao, et al.
Pageof 57